P30-CA16056/CA/NCI NIH HHS/United States[Grants and Funding] - Search Results

Year	Number of Results
1994	1
1998	3
1999	15
2000	1
2001	9
2002	10
2003	21
2004	17
2005	18
2006	15
2007	13
2008	3
2009	2
2010	1
2011	2
2012	1
2013	1
2014	2
2015	2
2016	1
2020	2
2022	1
2024	0

1

HLA-G and MIC expression in tumors and their role in anti-tumor immunity.

Seliger B, Abken H, Ferrone S. Seliger B, et al. Trends Immunol. 2003 Feb;24(2):82-7. doi: 10.1016/s1471-4906(02)00039-x. Trends Immunol. 2003. PMID: 12547505 Review.

2

Dicer in immune cell development and function.

Devasthanam AS, Tomasi TB. Devasthanam AS, et al. Immunol Invest. 2014;43(2):182-95. doi: 10.3109/08820139.2013.863557. Epub 2013 Dec 4. Immunol Invest. 2014. PMID: 24303839 Free PMC article. Review.

3

Classical and nonclassical HLA class I antigen and NK Cell-activating ligand changes in malignant cells: current challenges and future directions.

Chang CC, Campoli M, Ferrone S. Chang CC, et al. Adv Cancer Res. 2005;93:189-234. doi: 10.1016/S0065-230X(05)93006-6. Adv Cancer Res. 2005. PMID: 15797448 Review.

4

Differential in vivo and in vitro HLA-G expression in melanoma cells: potential mechanisms.

Chang CC, Murphy SP, Ferrone S. Chang CC, et al. Hum Immunol. 2003 Nov;64(11):1057-63. doi: 10.1016/j.humimm.2003.08.357. Hum Immunol. 2003. PMID: 14602236 Review.

5

RRM1-induced metastasis suppression through PTEN-regulated pathways.

Gautam A, Li ZR, Bepler G. Gautam A, et al. Oncogene. 2003 Apr 10;22(14):2135-42. doi: 10.1038/sj.onc.1206232. Oncogene. 2003. PMID: 12687015

6

Tumor microvasculature as a barrier to antitumor immunity.

Chen Q, Wang WC, Evans SS. Chen Q, et al. Cancer Immunol Immunother. 2003 Nov;52(11):670-9. doi: 10.1007/s00262-003-0425-4. Epub 2003 Aug 15. Cancer Immunol Immunother. 2003. PMID: 12920482 Free PMC article. Review. No abstract available.

7

Heat shock proteins HSP70 and GP96: structural insights.

Facciponte JG, Wang XY, MacDonald IJ, Park JE, Arnouk H, Grimm MJ, Li Y, Kim H, Manjili MH, Easton DP, Subjeck JR. Facciponte JG, et al. Cancer Immunol Immunother. 2006 Mar;55(3):339-46. doi: 10.1007/s00262-005-0020-y. Epub 2005 Jul 20. Cancer Immunol Immunother. 2006. PMID: 16032399 Free PMC article. Review.

8

Soluble HLA-A,-B,-C and -G molecules induce apoptosis in T and NK CD8+ cells and inhibit cytotoxic T cell activity through CD8 ligation.

Contini P, Ghio M, Poggi A, Filaci G, Indiveri F, Ferrone S, Puppo F. Contini P, et al. Eur J Immunol. 2003 Jan;33(1):125-34. doi: 10.1002/immu.200390015. Eur J Immunol. 2003. PMID: 12594841 Free article.

9

Bortezomib activity and in vitro interactions with anthracyclines and cytarabine in acute myeloid leukemia cells are independent of multidrug resistance mechanisms and p53 status.

Minderman H, Zhou Y, O'Loughlin KL, Baer MR. Minderman H, et al. Cancer Chemother Pharmacol. 2007 Jul;60(2):245-55. doi: 10.1007/s00280-006-0367-6. Epub 2006 Nov 10. Cancer Chemother Pharmacol. 2007. PMID: 17096161

10

Expression of the peripheral benzodiazepine receptor is decreased in skin cancers in comparison with normal skin.

Morgan J, Oseroff AR, Cheney RT. Morgan J, et al. Br J Dermatol. 2004 Oct;151(4):846-56. doi: 10.1111/j.1365-2133.2004.06198.x. Br J Dermatol. 2004. PMID: 15491426

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

127 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

127 results

Results by year